Should haemoglobin A1c be used for the diagnosis of diabetes mellitus in South Africa?

Journal of Endocrinology, Metabolism and Diabetes of South Africa

Volumn 16, Issue 3, 2011, Pages 122-127

  George, Jaya ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Diabetes; Fasting plasma glucose; Glycated haemoglobin; Oral glucose tolerance test

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

AGING; ANEMIA; DIABETES MELLITUS; ERYTHROCYTE; ETHNICITY; EYE PHOTOGRAPHY; GLUCOSE BLOOD LEVEL; GLYCATION; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEMOGLOBINOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; IRON DEFICIENCY; KIDNEY FAILURE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; QUALITY CONTROL; RETINOPATHY; REVIEW; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; STANDARDIZATION;

EID: 84865074057     PISSN: 16089677     EISSN: None     Source Type: Journal    
DOI: 10.1080/22201009.2011.10872263     Document Type: Review

References (46)

1. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
2. American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract. 2010;16:155-156.
3. World Health Organization (WHO). Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report. Geneva: WHO; 2009.
4. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med. 2007;24:333-343. (Pubitemid 46452406)
5. Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 2009;52:1279-1289.
6. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800-811.
7. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th edition. St Louis: Elsevier Saunders; 2006:859-860.
8. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med. 2007;167:1545-1551. (Pubitemid 47124186)
9. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1: S62-S69.
10. Troisi RJ, Cowie CC, Harris MI. Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. JAMA. 2000;284:3157-3159. (Pubitemid 32039079)
11. Stahl M, Jørgensen LG, Hyltoft Petersen P, et al. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest. 2001;61:169-179.
12. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem. 1989;35(2):315-317. (Pubitemid 19075618)
13. Motala AA, Esterhuizen T, Gouws E, et al. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care 2008;31:1783-1788.
14. Soma P, Rheeder P. Unsuspected glucose abnormalities in patients with coronary artery disease. S Afr Med J. 2006;96:216-220.
15. Ladenson JH, Tsai LM, Michael JM, et al. Serum versus heparinized plasma for eighteen common chemistry tests: is serum the appropriate specimen? Am J Clin Pathol.1974;62:545-552.
16. Gambino R, Piscitelli J, Ackattupathil TA, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem. 2009;55:1019-1021.
17. Miles RR, Roberts RF, Putnam AR, Roberts WL. Comparison of serum and heparinized plasma samples for measurement of chemistry analytes. Clin Chem. 2004;50:1704-1706. (Pubitemid 39121254)
18. Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48:436-472. (Pubitemid 34174577)
19. Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-ofcare instruments do not meet the general accepted analytical performance criteria. Clin Chem. 2010;56:44-52.
20. Little RR, Rohlfing CL, Wiedmeyer HM, et al. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem. 2001;47:1985-1992. (Pubitemid 33010715)
21. Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40:78-89. (Pubitemid 34196455)
22. Glesby MJ, Hoover DR, Shi Q, et al. Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study. Antivir Ther. 2010;15:571-577.
23. Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-2457. (Pubitemid 47547771)
24. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152:770-777.
25. Jørgensen ME, Bjerregaard P, Borch-Johnsen K, Witte D. New diagnostic criteria for diabetes: is the change from glucose to HbA1c possible in all populations? J Clin Endocrinol Metab. 2010;95:E333-E336.
26. Kim CH, Kim HK, Bae SJ, et al. Discordance between fasting glucose-based and hemoglobin A1c-based diagnosis of diabetes mellitus in Koreans. Diabetes Res Clin Pract. 2011;91:e8-e10.
27. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010;87:415-421.
28. Nowicka P, Santoro N, Liu H, et al. Utility of hemoglobin a1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 2011;34:1306-1311.
29. Coomunity survey 2007. StatsOnline [homepage on the Internet]. c2007. Available from: http://www.statssa.gov.za/community-new/content.asp
30. Naicker S. End-stage renal disease in sub-Saharan Africa. Ethn Dis. 2009;19(1 Suppl 1):S1-13-5.
31. Fluckiger R, Harmon W, Meier W, et al. Hemoglobin carbamylation in uremia. N Engl J Med. 1981;304:823-827. (Pubitemid 11147484)
32. Kovesdy CP, Sharma K, Kalantar-Zadeh K. Glycemic control in diabetic CKD patients: where do we stand? Am J Kidney Dis. 2008;52:766-777.
33. Eckhardt B, Holzman R, Kwan C, et al. Glycated hemoglobin A1C as screening for diabetes mellitus in HIV-infected individuals. Paper presented at:18th Conference on Retroviruses and Opportunistic Infections; 2011 Feb 27-Mar 2, Boston, MA, United States of America.
34. Hempe JM, Gomez R, McCarter RJ Jr., Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313-320.
35. Yudkin JS, Forrest RD, Jackson CA, et al. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990;33:208-215. (Pubitemid 20136237)
36. Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26:163-167. (Pubitemid 36929010)
37. Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284-4291.
38. Khera PK, Joiner CH, Carruthers A, et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 2008;57:2445-2452.
39. Snieder H, Sawtell PA, Ross L, et al. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001;50:2858-2863. (Pubitemid 33733139)
40. World Health Organization. Sickle Cell Anaemia. Geneva: WHO; 2005.
41. Kim C, Bullard KM, Herman WH, Beckles GL. Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010;33:780-785.
42. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112:126-128. (Pubitemid 39274157)
43. Lawrie D, Coetzee LM, Glencross DK. Iron deficiency anaemia in healthy South African women despite iron fortification. S Afr Med J. 2008;98:606-607.
44. Modjadji SEP. Folate and iron status of South African non-pregnant rural women of childbearing age, before and after fortification. S Afr J Clin Nutr. 2008;20:89-93. (Pubitemid 351285269)
45. Oelofse A, Faber M, Benade JG, et al. The nutritional status of a rural community in KwaZulu-Natal, South Africa: the Ndunakazi project. Cent Afr J Med. 1999;45:14-19.
46. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. (Pubitemid 38579764)